RARE IMPACT (2020-21)
Serving as Researcher Lead, I engaged with industry partners and patient communities to lead the research on the processes and selection criteria for Centres of Expertise for ATMPs for the Rare Impact consortium. Rare Impact aimed to identify and validate the challenges to patient access to gene and cell therapies, through engagement with HTA agencies, regulatory bodies, payers, patient groups, clinicians, manufacturers and other experts across Europe.